Clinical trials
Death, Sudden, Cardiac trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 3 |
| University Medical Center Goettingen | 2 |
| Amsterdam UMC, location VUmc | 1 |
| Charite University, Berlin, Germany | 1 |
| Gilead Sciences | 1 |
| Idoven 1903 S.L. | 1 |
| Radboud University Medical Center | 1 |
| University Medical Center Groningen | 1 |
| University of California, Los Angeles | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Death, Sudden, Cardiac | 12 |
| Arrhythmias, Cardiac | 5 |
| Heart Arrest | 5 |
| Cardiomyopathies | 3 |
| Tachycardia, Ventricular | 3 |
| Genetic Diseases, Inborn | 2 |
| Myocardial Infarction | 2 |
| Ventricular Fibrillation | 2 |
| Calcium Metabolism Disorders | 1 |
| Cardiac Conduction System Disease | 1 |
Trials
Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.